PRIMARY PERITONEAL CANCER
Clinical trials for PRIMARY PERITONEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PRIMARY PERITONEAL CANCER trials appear
Sign up with your email to follow new studies for PRIMARY PERITONEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Platinum-Resistant ovarian cancer: RC88 shows promise in early trial
Disease control CompletedThis study tested a new drug called RC88 in 43 women with ovarian, fallopian tube, or peritoneal cancer that stopped responding to platinum chemotherapy. The goal was to see if RC88 could shrink tumors and how safe it was. Participants had already tried at least three other treat…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE2 • Sponsor: RemeGen Co., Ltd. • Aim: Disease control
Last updated May 16, 2026 23:52 UTC
-
New drug combo shows promise for Hard-to-Treat ovarian cancer
Disease control CompletedThis study tested a combination of two drugs, pamiparib and surufatinib, in 29 women with a tough-to-treat type of ovarian cancer that had stopped responding to platinum chemotherapy and a prior PARP inhibitor. The goal was to see if the combo could shrink tumors or slow cancer g…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:58 UTC
-
New combo therapy shows promise in ovarian cancer fight
Disease control CompletedThis study tested adding immunotherapy drugs (nivolumab alone or with ipilimumab) to standard chemotherapy for people with advanced high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. The main goal was to check safety and find any serious side effects. 27 par…
Matched conditions: PRIMARY PERITONEAL CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Real-World check: does ovarian cancer drug match trial results?
Knowledge-focused CompletedThis study looked back at the medical records of 51 people with ovarian, fallopian tube, or peritoneal cancer who took the drug rucaparib. The goal was to see how well the drug works and how safe it is in real-world patients, not just in strict clinical trials. Researchers collec…
Matched conditions: PRIMARY PERITONEAL CANCER
Sponsor: Grupo Español de Investigación en Cáncer de Ovario • Aim: Knowledge-focused
Last updated May 16, 2026 23:49 UTC